TNK BIOTECH ApS: Financial statements 2024
CVR: 30691911
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
TNK BIOTECH ApS (CVR 30691911) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -11,063 and a net result of DKK -15,724 compared with DKK -11,197 the year before. Equity in the 2024 report amounted to DKK -64,626. The company had 1 employee in the financial year.
- Gross Profit
- DKK -11,063
- Profit/Loss
- DKK -15,724
- Equity
- DKK -64,626
- Total Assets
- DKK 40,752
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -11 t. | -16 t. | -65 t. | 1 |
| 2023 | - | -9 t. | -11 t. | -49 t. | 1 |
| 2022 | - | -10 t. | -13 t. | -38 t. | 1 |
| 2021 | - | -11 t. | -14 t. | -25 t. | 1 |
| 2020 | - | -14 t. | -19 t. | -10 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
TNK BIOTECH ApS has published its annual report for 2023. Gross profit came to DKK -9,250, and the net result was DKK -11,197.
About TNK BIOTECH ApS
TNK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2007. The company is registered under the industry Investering for egen regning. The company was previously named TNK INVEST ApS. The management consists of Thomas Nitschke Kledal. The company is owned by Thomas Nitschke Kledal. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154.